Research Disclaimer & Legal Notice Important Research Use Only Statement: This BPC-157 research peptide is supplied exclusively for in-vitro laboratory research and scientific investigation purposes
-
We keep our peptide pricing as low as possible, so we recommend sourcing your own supplies for the best quality and value
A direct detrimental incretin effect on the central nervous system could also be hypothesized and susceptible people receiving GLP-1 RAs may, in some circumstances, experience a worsening of hedonic tone predisposing psychopathology and/or self-harm ideation and/or other aspects of suicidality
Results vary based on B12 levels, sleep, nutrition, stress, activity level, and overall health
In 2023, the FDA classified BPC-157 as a Category 2 bulk drug substance, restricting its use by compounding pharmacies